Medical product companies that figure out how to embrace and most effectively apply emerging analytic and digital health technologies, and think creatively about new risk-sharing business models, will be best positioned to deliver impactful medicines to patients, durable health to populations, and long...
Posted to
News
by
Health. Care.
on
Sat, Mar 23 2013
Filed under:
Filed under: health, Pharma & Healthcare, byline=David Shaywitz, Strategy, Analytics, Phenotype, Data Driven, digital health, big data, biopharmaceutical, Building the Organization of Tomorrow, ticker=NASDAQ:GOOG, ticker=NASDAQ:AMGN, ticker=NASDAQ:FB, ticker=NYSE:AZN
Big data may be the future of health; should biopharma invest in this capability now or continue to wait? Read More...
Posted to
News
by
Health. Care.
on
Fri, Jul 27 2012
Filed under:
Filed under: Health IT, health, google, Pharma & Healthcare, byline=David Shaywitz, Data Driven, digital health, big data, Building the Organization of Tomorrow, ticker=NASDAQ:GOOG, palantir, database, ticker=NASDAQ:MSFT
Profound change is far more likely to originate not from a process-laden organization leveraging scale but rather from an impassioned, narrative-driven company, formed around a compelling idea that’s engaged the mind and spirit of small number of highly motivated people, viscerally driven to pursue this...
Posted to
News
by
Health. Care.
on
Thu, May 17 2012
Filed under:
Filed under: Facebook, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Entrepreneurs, Silicon Valley, TechCrunch, Building the Organization of Tomorrow, ticker=NASDAQ:GOOG, Rich Karlgaard, Instagram, Quora, ticker=NASDAQ:FB
If you don’t think this is a dispiriting time to be in Big Pharma, you obviously haven’t spent time with anyone who works there, laboring in the trenches. I have – in fact, I’ve spent the last several days at a professional workshop with a number of colleagues from a range of companies – and [...] Read...
Posted to
News
by
Health. Care.
on
Fri, Mar 16 2012
Filed under:
Filed under: health, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Pharma, Pfizer, big pharma, Building the Organization of Tomorrow, ticker=NASDAQ:AMZN, ticker=NASDAQ:GOOG, Celgene, ticker=NASDAQ:CELG, Gilead, ticker=NYSE:PFE, ticker=NASDAQ:GILD
Reid Hoffman’s talk this week at Stanford (podcast and video available here) touched on several themes that collectively seem to comprise the Silicon Valley innovator ethos; most are relevant to healthcare and biopharma, and I agree with all his assertions except one. (Hoffman, for those tuning in late...
Posted to
News
by
Health. Care.
on
Thu, Feb 23 2012
Filed under:
Filed under: Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Silicon Valley, Management, LinkedIn, entrepreneur, PayPal, Building the Organization of Tomorrow, ticker=NASDAQ:GOOG, ticker=NYSE:LNKD, Reid Hoffman, Greylock Partners